Skip to main content
HR 701 117th Congress House Government Operations and Politics Administrative law and regulatory procedures Competition and antitrust Congressional oversight Consumer affairs Economic performance and conditions Federal Reserve System Federal-Indian relations Government information and archives Government studies and investigations Intergovernmental relations Judicial review and appeals Labor market Monetary policy Office of Management and Budget (OMB) Performance measurement Small business State and local finance

Unfunded Mandates Accountability and Transparency Act

Introduced: February 2, 2021 Introduced by: Foxx, Virginia Republican · North Carolina See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 22, 2021
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Feb 2, 2021
Referred to the Committee on Oversight and Reform, and in addition to the Committees on Rules, the Budget, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 2, 2021
Introduced in House
 Plain-English summary Congressional Research Service

Unfunded Mandates Accountability and Transparency Act

This bill revises rulemaking requirements with respect to unfunded mandates.

Specifically, the bill requires federal agencies to prepare and publish in the Federal Register an initial and final regulatory impact analysis prior to promulgating any proposed or final major rule. The analysis must include regulatory alternatives to the rule.

Major rule means a rule that the Office of Information and Regulatory Affairs determines is likely to cause

  • an annual effect on the economy of $100 million or more;
  • a major increase in costs or prices for consumers, individual industries, federal, state, local, or tribal government agencies, or geographic regions; or
  • significant adverse effects on competition, employment, investment, productivity, innovation, public health and safety, or the ability of U.S.-based enterprises to compete with foreign-based enterprises in domestic and export markets.

Before promulgating any proposed or final major rule, an agency shall select the regulatory alternative that maximizes net benefits, taking into consideration only the costs and benefits that arise within the scope of the statutory provision that authorizes the rulemaking, with exceptions.

The bill prohibits Congress from considering a bill that increases private sector costs more than a certain amount unless certain conditions are met.

What's happening now March 22, 2021

Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

 Committees of jurisdiction 5